- Home
- STAA vs ADNT Comparison
STAA vs ADNT Comparison
Compare STAA & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- ADNT
- Stock Information
- Founded
- STAA 1982
- ADNT 2016
- Country
- STAA United States
- ADNT Ireland
- Employees
- STAA N/A
- ADNT N/A
- Industry
- STAA Ophthalmic Goods
- ADNT Auto Parts:O.E.M.
- Sector
- STAA Health Care
- ADNT Consumer Discretionary
- Exchange
- STAA Nasdaq
- ADNT Nasdaq
- Market Cap
- STAA 850.9M
- ADNT 1.6B
- IPO Year
- STAA N/A
- ADNT N/A
- Fundamental
- Price
- STAA $17.17
- ADNT $22.72
- Analyst Decision
- STAA Hold
- ADNT Hold
- Analyst Count
- STAA 8
- ADNT 9
- Target Price
- STAA $27.17
- ADNT $17.31
- AVG Volume (30 Days)
- STAA 758.1K
- ADNT 1.3M
- Earning Date
- STAA 08-06-2025
- ADNT 08-06-2025
- Dividend Yield
- STAA N/A
- ADNT N/A
- EPS Growth
- STAA N/A
- ADNT N/A
- EPS
- STAA N/A
- ADNT N/A
- Revenue
- STAA $279,134,000.00
- ADNT $14,384,000,000.00
- Revenue This Year
- STAA N/A
- ADNT N/A
- Revenue Next Year
- STAA $27.83
- ADNT N/A
- P/E Ratio
- STAA N/A
- ADNT N/A
- Revenue Growth
- STAA N/A
- ADNT N/A
- 52 Week Low
- STAA $13.50
- ADNT $10.04
- 52 Week High
- STAA $49.86
- ADNT $26.59
- Technical
- Relative Strength Index (RSI)
- STAA 49.02
- ADNT 78.91
- Support Level
- STAA $16.52
- ADNT $22.08
- Resistance Level
- STAA $18.00
- ADNT $23.35
- Average True Range (ATR)
- STAA 0.69
- ADNT 0.74
- MACD
- STAA 0.09
- ADNT 0.13
- Stochastic Oscillator
- STAA 53.85
- ADNT 86.54
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About ADNT Adient plc
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion but will likely be below $14 billion in fiscal 2025 on tariff interruptions and divesting some lower-quality business.